# Jacob Lange Moresco

> Jacob Lange Moresco is a Series A investor at Sunstone Life Science Ventures backing Biotechnology. See 2 investments, check sizes, portfolio. Updated Aug 2026.

- Type: Angel Investor
- Fund: [Sunstone Life Science Ventures](https://shizune.co/investors/profile/sunstone-capital-life-science)
- Location: Copenhagen, Denmark
- Total investments: 2
- Last investment: Nov 2023
- Lead investor: 50%
- Last updated: Aug 2026
- LinkedIn: http://www.linkedin.com/in/langemoresco

Jacob Lange Moresco is a Series A investor at Sunstone Life Science Ventures in Copenhagen focused on Biotechnology and Medical. Jacob Moresco joined the Life Science team as an associate in 2010. Jacob focuses on deal flow management and data analysis. He is also closely involved in due diligence investigations and the execution of internal investment documents.Previously, Jacob held a Post Doc position at the department for micro- and nanotechnology at the TechnicalUniversity of Denmark (DTU). His industry experience includes drug discovery and software tool development at TopoTarget and Chr. Hansen, respectively. Jacob holds a Master’s degree in Biotech Engineering and a PhD in the fields of microfabrication, microfluidics, and diagnostics – both from DTU. Out-of-office hours are divided between time with the family and outdoor activities such as fly fishing, badminton, cycling, running, and free diving spear hunting.

## Investment focus

### Industry

| Industry | Investments | Share |
| --- | --- | --- |
| Biotechnology | 2 | 100% |
| Medical | 1 | 50% |
| Health Care | 1 | 50% |
| Therapeutics | 1 | 50% |
| Pharmaceutical | 1 | 50% |

### Stage

| Stage | Investments | Share |
| --- | --- | --- |
| Series A | 1 | 50% |
| Series B | 1 | 50% |

## Investments

| Company | Description | Amount | Stage | Date | Website |
| --- | --- | --- | --- | --- | --- |
| Kynexis | Kynexis is advancing the first potential precision medicine for the treatment of cognitive impairment associated with schizophrenia (CIAS). | $61M | Series A | Nov 07, 2023 |  |
| Step Pharma | Step Pharma is a spin-off of Imagine Institute stemming from Pr. Alain Fischer’s research on genetic immunodeficiencies. Step Pharma is a joint venture between Imagine, a research and innovative healthcare institute, Sygnature Discovery, a leading provider of integrated drug discovery resource and expertise, and Kurma Partners, a major player inthe funding of healthcare and biotechnology in Europe. | $41.3M | Series B | Mar 24, 2021 |  |

2 of 2 investments shown.

## Co-investors
- [Forbion Capital Partners](https://shizune.co/investors/profile/forbion-capital-partners) — VC Fund, 2 deals together
- [Ysios Capital](https://shizune.co/investors/profile/ysios-capital) — VC Fund, 2 deals together
- [Bpifrance](https://shizune.co/investors/profile/bpifrance) — VC Fund, 1 deal together
- [Hadean Ventures](https://shizune.co/investors/profile/hadean-ventures) — VC Fund, 1 deal together
- [Kurma Partners](https://shizune.co/investors/profile/kurma-life-science-partners) — VC Fund, 1 deal together
- [Pontifax](https://shizune.co/investors/profile/pontifax) — VC Fund, 1 deal together

## About Sunstone Life Science Ventures

VC Fund · Copenhagen, Denmark

Sunstone Life Science Ventures is a European, early-stage VC investing in novel pharmaceutical ingredients for human therapeutic use

5 contacts available at Sunstone Life Science Ventures.

| Name | Title | Profile |
| --- | --- | --- |
| Claus A. Andersson | General Partner | https://shizune.co/investors/profile/claus-andersson |
| Jacob Lange Moresco | Investment Director | https://shizune.co/investors/profile/jacob-lange-moresco |
| Line Jacobsen | Management Assistant | https://shizune.co/investors/profile/line-jacobsen |
| Peter Benson | Chairman and Managing Partner | https://shizune.co/investors/profile/peter-benson |
| Sten Verland | Co-Founder & General Partner | https://shizune.co/investors/profile/sten-verland |

## Similar investors

### Similar stage
- [Antler](https://shizune.co/investors/profile/antler-be9c) — VC Fund
- [Alumni Ventures](https://shizune.co/investors/profile/alumni-ventures-group) — VC Fund
- [General Catalyst](https://shizune.co/investors/profile/general-catalyst-partners) — VC Fund

## FAQ

### What does Jacob Lange Moresco invest in?

Jacob Lange Moresco invests primarily in Biotechnology, Medical and Health Care startups, most often at Series A and Series B stage. Most of the 2 investments tracked by Shizune back companies in France. The Investment Focus section breaks down every industry, stage and country in the portfolio.

### When did Jacob Lange Moresco last invest?

The most recent investment recorded for Jacob Lange Moresco closed in Nov 2023. Shizune tracks 2 investments in total for this profile, including round sizes, stages and portfolio companies, all sourced from confirmed public funding rounds and refreshed monthly.

### Is Shizune's investor data accurate?

Yes — every stat on this profile is calculated from confirmed public funding rounds monitored across hundreds of sources since 2020. This profile was last refreshed in Aug 2026 and is updated monthly. Spotted something off? Use the “Suggest an edit” link near the top of the page.

# About Shizune
Shizune.co is an investor database. Core features:
- 48,091 startup investors (angels, VCs, accelerators, and others)
- Email, phone, LinkedIn (for intros), socials, and other contact data
- Updated daily from public funding news
- CSV and Excel export

The User can access the full database FOR FREE after signing up: shizune.co